Skip to main content

Table 2 Comparison of the treatment and prognosis among choriocarcinoma arising from mole vs from biparental pregnancy vs non-gestational Choriocarcinoma

From: Using short tandem repeat analysis for choriocarcinoma diagnosis: a case series

   choriocarcinoma arising from mole (n = 9) Choriocarcinoma from biparental pregnancy (n = 5) non-gestational choriocarcinoma (n = 1)
Surgery (n, %) Hysterectomy 2 (22%) 2 (40%) 0
Uterine curetting 5 (56%) 2 (40%) 0
Pelvic mass resection 1 (11%) 0 1 (100%)
Adnexectomy 1 (11%) 1 (420%) 1 (100%)
Prognosis(n) Alive, no evidence of disease 9 5  
Lost of follow-up    1
Chemotherapy (n, %) First-line single-agent alone 3 (33.3%) 0 0
First-line multi-agent alone 4 (44.4%) 2 (40%) 1 (100%)
Salvage multi-agent chemotherapy 2 (22.2%) 3 (60%) 0